The study published in the American Journal of Cancer Research shows that the Food and Drug Administration-approved medication crizotinib (also known by its name brand, Xalkori) is effective at inhibiting the growth of non-small cell lung cancer with the most common genetic mutations.
Existing Drug Shows Promise in Treating Most Prevalent Type of Lung Cancer miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Existing drug shows promise treating most prevalent type of lung cancer medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Markey's ACTION alumni set to take on Appalachia's cancer crisis uky.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uky.edu Daily Mail and Mail on Sunday newspapers.
A University of Kentucky Markey Cancer Center researcher’s team developed new chemical compounds that show promise as a potential anticancer therapy to treat
A University of Kentucky Markey Cancer Center researcher's team developed new chemical compounds that show promise as a potential anticancer therapy to treat aggressive tumors.
Markey researchers create new cancer fighting compound uky.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uky.edu Daily Mail and Mail on Sunday newspapers.
University of Kentucky researchers create new cancer fighting compound miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
New cancer fighting compound created miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.